tradingkey.logo
tradingkey.logo
Search

IRadimed Corp

IRMD
Add to Watchlist
90.860USD
-4.350-4.57%
Close 07-31 16:00ETQuotes delayed by 15 min
1.16BMarket Cap
49.02P/E TTM

IRMD Income Statement

You can find the annual or quarterly income statement of IRadimed Corp here for insights into the performance and operational efficiency of IRadimed Corp.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
Total revenue
12.65%21.98M
17.03%22.69M
15.69%21.20M
13.84%20.41M
10.87%19.51M
11.10%19.39M
11.04%18.33M
11.15%17.93M
13.72%17.60M
17.42%17.45M
23.10%16.50M
26.80%16.13M
25.70%15.48M
25.19%14.86M
22.92%13.41M
29.67%12.72M
33.46%12.31M
38.93%11.87M
41.67%10.91M
44.38%9.81M
6.30%9.22M
-21.53%8.55M
-22.73%7.70M
-26.35%6.79M
2.84%8.68M
30.59%10.89M
30.84%9.96M
25.06%9.23M
18.70%8.44M
24.38%8.34M
33.83%7.61M
33.53%7.38M
37.69%7.11M
11.93%6.70M
-25.85%5.69M
-44.02%5.52M
-42.41%5.16M
-31.92%5.99M
-6.35%7.67M
29.70%9.87M
28.21%8.96M
145.55%8.80M
114.95%8.19M
61.88%7.61M
96.55%6.99M
3.66%3.58M
53.72%3.81M
69.38%4.70M
35.35%3.56M
--3.46M
--2.48M
--2.78M
--2.63M
Revenue
12.65%21.98M
17.03%22.69M
15.69%21.20M
13.84%20.41M
10.87%19.51M
11.10%19.39M
11.04%18.33M
11.15%17.93M
13.72%17.60M
17.42%17.45M
23.10%16.50M
26.80%16.13M
25.70%15.48M
25.19%14.86M
22.92%13.41M
29.67%12.72M
33.46%12.31M
38.93%11.87M
41.67%10.91M
44.38%9.81M
6.30%9.22M
-21.53%8.55M
-22.73%7.70M
-26.35%6.79M
2.84%8.68M
30.59%10.89M
30.84%9.96M
25.06%9.23M
18.70%8.44M
24.38%8.34M
33.83%7.61M
33.53%7.38M
37.69%7.11M
11.93%6.70M
-25.85%5.69M
-44.02%5.52M
-42.41%5.16M
-31.92%5.99M
-6.35%7.67M
29.70%9.87M
28.21%8.96M
145.55%8.80M
114.95%8.19M
61.88%7.61M
96.55%6.99M
3.66%3.58M
53.72%3.81M
69.38%4.70M
35.35%3.56M
--3.46M
--2.48M
--2.78M
--2.63M
Cost of revenue
10.65%5.17M
22.29%5.66M
13.87%4.71M
13.65%4.45M
10.86%4.67M
14.58%4.63M
12.73%4.13M
-0.62%3.92M
12.17%4.21M
10.87%4.04M
28.02%3.67M
52.76%3.94M
28.06%3.75M
38.89%3.64M
14.50%2.86M
4.18%2.58M
35.60%2.93M
24.52%2.62M
27.77%2.50M
32.90%2.48M
-2.35%2.16M
-23.17%2.11M
-9.69%1.96M
0.34%1.86M
8.10%2.21M
38.30%2.74M
18.69%2.17M
8.62%1.86M
21.06%2.05M
20.87%1.98M
39.68%1.83M
38.61%1.71M
21.90%1.69M
25.77%1.64M
-6.98%1.31M
-29.02%1.23M
-18.65%1.39M
-13.06%1.30M
-11.59%1.41M
22.29%1.74M
28.43%1.71M
63.27%1.50M
65.72%1.59M
63.50%1.42M
102.35%1.33M
-3.17%918.70K
43.27%959.59K
13.29%869.75K
40.52%656.37K
--948.79K
--669.76K
--767.72K
--467.11K
Operating expenses
4.71%14.74M
14.79%15.60M
14.61%14.37M
10.73%13.62M
9.57%14.08M
10.55%13.59M
18.28%12.54M
10.16%12.30M
12.05%12.85M
15.86%12.29M
14.28%10.60M
30.54%11.17M
24.17%11.47M
21.07%10.61M
18.60%9.27M
7.39%8.55M
24.02%9.24M
11.00%8.76M
13.10%7.82M
-18.08%7.97M
-6.21%7.45M
-8.75%7.90M
-7.12%6.91M
41.96%9.72M
14.68%7.94M
32.16%8.65M
20.72%7.44M
20.14%6.85M
15.00%6.92M
14.75%6.55M
12.25%6.17M
9.71%5.70M
11.48%6.02M
27.20%5.71M
8.15%5.49M
-20.40%5.20M
-1.49%5.40M
-17.66%4.49M
1.78%5.08M
32.82%6.53M
17.36%5.48M
62.21%5.45M
46.54%4.99M
59.06%4.92M
70.93%4.67M
22.82%3.36M
60.35%3.41M
54.87%3.09M
60.83%2.73M
--2.73M
--2.12M
--2.00M
--1.70M
R&D expenses
53.14%956.00K
40.18%799.03K
5.46%674.36K
9.52%877.36K
-83.69%624.25K
-12.37%569.99K
41.30%639.47K
-16.72%801.13K
382.18%3.83M
7.56%650.43K
-7.95%452.56K
45.18%961.95K
52.90%793.72K
22.21%604.74K
2.28%491.64K
46.05%662.60K
9.10%519.10K
-3.48%494.85K
0.80%480.70K
-6.00%453.68K
10.58%475.82K
35.17%512.72K
29.05%476.88K
45.68%482.65K
22.04%430.28K
3.15%379.31K
-1.09%369.53K
-16.33%331.31K
-7.18%352.57K
5.19%367.71K
-2.38%373.58K
-11.81%395.99K
-29.83%379.83K
-4.02%349.56K
-16.28%382.70K
53.86%449.01K
130.99%541.29K
-27.16%364.22K
-11.85%457.13K
-27.67%291.82K
-31.54%234.34K
58.52%500.00K
70.88%518.56K
78.91%403.45K
52.61%342.30K
-8.74%315.41K
1.35%303.46K
10.31%225.50K
39.83%224.30K
--345.62K
--299.42K
--204.42K
--160.41K
Depreciation, depletion, and amortization
134.39%455.00K
95.35%380.68K
94.22%383.72K
4.19%207.48K
-14.14%194.12K
-5.12%194.87K
4.04%197.57K
6.28%199.13K
23.85%226.09K
17.48%205.38K
-56.39%189.90K
-62.09%187.36K
-57.93%182.55K
-54.78%174.82K
28.03%435.48K
41.88%494.18K
30.78%433.93K
14.04%386.60K
2.76%340.13K
7.49%348.30K
-3.77%331.79K
20.76%339.01K
14.56%330.99K
13.46%324.04K
-10.93%344.78K
7.92%280.73K
82.46%288.92K
-29.03%285.60K
-9.51%387.08K
-23.05%260.12K
-79.48%158.35K
250.07%402.42K
408.80%427.75K
428.04%338.03K
1153.99%771.68K
85.60%114.95K
38.01%84.07K
6.28%64.02K
7.13%61.54K
12.70%61.94K
18.72%60.91K
21.88%60.23K
27.16%57.45K
63.11%54.96K
147.06%51.31K
20.25%49.42K
37.92%45.18K
1.50%33.69K
-35.09%20.77K
--41.09K
--32.76K
--33.20K
--32.00K
Operating profit
33.24%7.24M
22.30%7.09M
18.04%6.83M
20.63%6.79M
14.39%5.43M
12.41%5.80M
-1.97%5.79M
13.38%5.63M
18.49%4.75M
21.30%5.16M
42.91%5.91M
19.12%4.96M
30.32%4.01M
36.80%4.25M
33.87%4.13M
125.93%4.17M
73.04%3.07M
377.64%3.11M
293.36%3.09M
162.96%1.84M
141.04%1.78M
-70.92%651.03K
-68.84%784.76K
-223.29%-2.93M
-51.30%737.24K
24.88%2.24M
73.94%2.52M
41.80%2.38M
39.23%1.51M
79.33%1.79M
638.59%1.45M
411.49%1.68M
556.13%1.09M
-33.58%999.75K
-92.44%196.06K
-90.19%327.57K
-106.85%-238.38K
-55.10%1.51M
-19.02%2.59M
23.99%3.34M
50.06%3.48M
1387.31%3.35M
688.28%3.20M
67.30%2.69M
181.52%2.32M
-68.82%225.38K
14.18%406.31K
106.51%1.61M
-11.28%824.08K
--722.85K
--355.84K
--779.70K
--928.83K
Net non-operating interest income (expenses)
Gains from sale of securities
----
----
----
----
----
----
----
----
----
---148.84K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
57.87%-24.00K
----
----
----
-143.12%-56.97K
----
200.00%3.00K
----
---23.43K
----
--1.00K
---4.39K
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
---55.43K
----
----
----
----
----
----
----
----
- Gains from disposal of fixed assets
----
----
----
----
----
68.96%-3.87K
----
----
----
---12.47K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-672.31%-12.28K
----
----
----
111.76%2.15K
----
-60.30%8.63K
----
---18.24K
----
--21.74K
--1.05K
Other non-operating income (expenses)
3.51%532.00K
27.15%696.80K
-26.26%463.98K
-16.03%539.25K
3.80%513.97K
-19.78%548.03K
25.04%629.20K
91.49%642.22K
44.61%495.15K
51.90%683.13K
378.40%503.19K
2459.82%335.39K
2395.74%342.41K
11343.59%449.73K
1372.53%105.18K
-0.70%13.10K
-163.38%-14.91K
-70.90%3.93K
-23.62%7.14K
-26.09%13.20K
-105.75%-5.66K
-88.28%13.51K
-91.50%9.35K
-77.12%17.85K
6.40%98.50K
38.73%115.25K
158.64%110.06K
180.28%78.03K
131.02%92.57K
159.60%83.07K
48.20%42.55K
31.70%27.84K
35.73%40.07K
233.75%32.00K
814.84%28.71K
552.73%21.14K
-7.09%29.52K
--9.59K
-106.21%-4.02K
-110.12%-4.67K
-32.12%31.78K
----
834.66%64.71K
--46.13K
1256.17%46.81K
----
-146.81%-8.81K
----
--3.45K
----
--18.82K
----
----
Income before tax
30.67%7.77M
22.80%7.79M
13.70%7.30M
16.88%7.33M
13.39%5.95M
11.66%6.34M
0.15%6.42M
18.32%6.27M
20.55%5.24M
20.79%5.68M
51.23%6.41M
26.77%5.30M
42.15%4.35M
51.07%4.70M
36.96%4.24M
125.03%4.18M
72.75%3.06M
368.52%3.11M
289.62%3.09M
163.80%1.86M
111.95%1.77M
-71.77%664.53K
-69.79%794.11K
-218.64%-2.91M
-47.98%835.74K
25.49%2.35M
76.36%2.63M
44.06%2.45M
42.49%1.61M
81.82%1.88M
563.17%1.49M
388.47%1.70M
639.79%1.13M
-31.89%1.03M
-91.32%224.78K
-89.55%348.71K
-105.95%-208.86K
-54.32%1.51M
-20.75%2.59M
21.74%3.34M
51.99%3.51M
1844.14%3.32M
722.03%3.27M
68.94%2.74M
179.30%2.31M
-74.96%170.55K
6.10%397.50K
102.10%1.62M
-10.58%827.53K
--681.18K
--374.66K
--802.44K
--925.49K
Income tax
55.09%1.95M
12.61%1.35M
25.73%1.72M
13.54%1.55M
13.64%1.26M
4.87%1.20M
2.05%1.37M
22.30%1.37M
17.31%1.11M
10.87%1.14M
65.52%1.34M
19.17%1.12M
64.59%943.59K
232.19%1.03M
56.51%810.38K
142.09%938.63K
49.10%573.29K
-194.20%-779.17K
284.56%517.77K
148.53%387.73K
141.19%384.49K
193.19%827.12K
-261.20%-280.54K
-318.91%-798.99K
-290.34%-933.47K
-625.47%-887.52K
119.13%174.03K
4.77%364.99K
-183.56%-239.15K
-54.87%168.90K
-2908.85%-909.62K
4267.19%348.38K
1068.97%286.20K
0.06%374.22K
-96.85%32.38K
-100.76%-8.36K
-98.01%24.48K
-58.95%374.01K
-26.52%1.03M
13.91%1.10M
49.43%1.23M
1008.67%911.10K
774.47%1.40M
60.76%969.28K
170.85%823.83K
-148.39%-100.27K
40.50%160.14K
146.97%602.93K
8.03%304.17K
--207.20K
--113.98K
--244.13K
--281.57K
Income after tax
24.12%5.82M
25.16%6.44M
10.44%5.58M
17.81%5.77M
13.32%4.69M
13.37%5.15M
-0.35%5.05M
17.26%4.90M
21.45%4.14M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
-5.63%3.67M
33.03%3.43M
120.53%3.24M
79.31%2.49M
2494.22%3.89M
139.73%2.58M
169.58%1.47M
-21.61%1.39M
-105.02%-162.59K
-56.22%1.07M
-201.12%-2.11M
-4.14%1.77M
89.90%3.24M
2.27%2.45M
54.16%2.09M
119.40%1.85M
159.61%1.71M
1147.59%2.40M
279.47%1.35M
460.50%841.20K
-42.36%657.54K
-87.67%192.39K
-84.00%357.07K
-110.23%-233.34K
-52.56%1.14M
-16.42%1.56M
26.02%2.23M
53.41%2.28M
787.93%2.40M
686.64%1.87M
73.79%1.77M
184.22%1.49M
-42.86%270.82K
-8.95%237.36K
82.48%1.02M
-18.72%523.37K
--473.98K
--260.68K
--558.31K
--643.93K
Net income from continuous operations
24.12%5.82M
25.16%6.44M
10.44%5.58M
17.81%5.77M
13.32%4.69M
13.37%5.15M
-0.35%5.05M
17.26%4.90M
21.45%4.14M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
-5.63%3.67M
33.03%3.43M
120.53%3.24M
79.31%2.49M
2494.22%3.89M
139.73%2.58M
169.58%1.47M
-21.61%1.39M
-105.02%-162.59K
-56.22%1.07M
-201.12%-2.11M
-4.14%1.77M
89.90%3.24M
2.27%2.45M
54.16%2.09M
119.40%1.85M
159.61%1.71M
1147.59%2.40M
279.47%1.35M
460.50%841.20K
-42.36%657.54K
-87.67%192.39K
-84.00%357.07K
-110.23%-233.34K
-52.56%1.14M
-16.42%1.56M
26.02%2.23M
53.41%2.28M
787.93%2.40M
686.64%1.87M
73.79%1.77M
184.22%1.49M
-42.86%270.82K
-8.95%237.36K
82.48%1.02M
-18.72%523.37K
--473.98K
--260.68K
--558.31K
--643.93K
Non-recurring net income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--800.00K
----
----
----
----
----
----
----
----
----
----
----
---473.90K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
24.12%5.82M
25.16%6.44M
10.44%5.58M
17.81%5.77M
13.32%4.69M
13.37%5.15M
-0.35%5.05M
17.26%4.90M
21.45%4.14M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
-5.63%3.67M
33.03%3.43M
120.53%3.24M
79.31%2.49M
510.70%3.89M
139.73%2.58M
169.58%1.47M
-21.61%1.39M
-80.34%637.41K
-56.22%1.07M
-201.12%-2.11M
-4.14%1.77M
89.90%3.24M
2.27%2.45M
54.16%2.09M
119.40%1.85M
829.55%1.71M
1147.59%2.40M
279.47%1.35M
460.50%841.20K
-83.90%183.64K
-87.67%192.39K
-84.00%357.07K
-110.23%-233.34K
-52.56%1.14M
-16.42%1.56M
26.02%2.23M
53.41%2.28M
787.93%2.40M
686.64%1.87M
73.79%1.77M
184.22%1.49M
-42.86%270.82K
-8.95%237.36K
82.48%1.02M
-18.72%523.37K
--473.98K
--260.68K
--558.31K
--643.93K
Net income attributable to common shareholders
24.12%5.82M
25.16%6.44M
10.44%5.58M
17.81%5.77M
13.32%4.69M
13.37%5.15M
-0.35%5.05M
17.26%4.90M
21.45%4.14M
23.58%4.54M
47.86%5.07M
28.97%4.18M
36.97%3.41M
-5.63%3.67M
33.03%3.43M
120.53%3.24M
79.31%2.49M
510.70%3.89M
139.73%2.58M
169.58%1.47M
-21.61%1.39M
-80.34%637.41K
-56.22%1.07M
-201.12%-2.11M
-4.14%1.77M
89.90%3.24M
2.27%2.45M
54.16%2.09M
119.40%1.85M
829.55%1.71M
1147.59%2.40M
279.47%1.35M
460.50%841.20K
-83.90%183.64K
-87.67%192.39K
-84.00%357.07K
-110.23%-233.34K
-52.56%1.14M
-16.42%1.56M
26.02%2.23M
53.41%2.28M
787.93%2.40M
686.64%1.87M
73.79%1.77M
184.22%1.49M
-42.86%270.82K
-8.95%237.36K
82.48%1.02M
-18.72%523.37K
--473.98K
--260.68K
--558.31K
--643.93K
Basic earnings per share
23.45%0.46
24.64%0.51
10.00%0.44
17.34%0.45
12.86%0.37
12.80%0.41
-0.88%0.40
16.62%0.39
20.78%0.33
23.12%0.36
47.41%0.40
28.61%0.33
36.53%0.27
-6.71%0.29
30.56%0.27
116.18%0.26
75.84%0.20
503.45%0.31
138.03%0.21
168.24%0.12
-24.28%0.11
-81.49%0.05
-59.35%0.09
-193.48%-0.17
-11.09%0.15
79.81%0.28
-2.63%0.22
47.09%0.19
111.01%0.17
797.12%0.16
1117.74%0.22
280.75%0.13
465.10%0.08
-83.67%0.02
-87.53%0.02
-83.86%0.03
-110.56%-0.02
-50.85%0.11
-13.73%0.15
28.31%0.21
50.79%0.21
766.01%0.22
621.35%0.17
10.85%0.16
82.41%0.14
-46.45%0.03
-8.61%0.02
164.59%0.15
17.86%0.07
--0.05
--0.03
--0.06
--0.06
Diluted earnings per share
23.13%0.45
24.75%0.50
9.74%0.43
17.10%0.45
12.65%0.37
12.42%0.40
-0.68%0.40
16.94%0.38
20.84%0.32
22.54%0.36
46.64%0.40
28.05%0.33
36.64%0.27
-5.49%0.29
32.73%0.27
119.17%0.26
77.40%0.20
504.18%0.31
137.63%0.20
166.93%0.12
-22.59%0.11
-80.58%0.05
-56.86%0.09
-202.38%-0.17
-5.20%0.14
88.36%0.26
1.33%0.20
51.44%0.17
113.15%0.15
790.72%0.14
1091.34%0.20
270.48%0.11
426.01%0.07
-83.84%0.02
-87.44%0.02
-83.67%0.03
-111.73%-0.02
-46.32%0.10
-12.80%0.13
27.50%0.19
49.08%0.19
685.87%0.18
616.00%0.15
27.43%0.15
106.98%0.12
-50.90%0.02
-17.99%0.02
108.62%0.11
-5.42%0.06
--0.05
--0.03
--0.06
--0.06
Dividend per share
17.65%0.20
13.33%0.17
13.33%0.17
13.33%0.17
--0.17
0.00%0.15
--0.15
--0.15
--0.00
--0.15
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read IRadimed Corp's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing IRMD stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was IRadimed Corp's revenue at year end?

IRadimed Corp reported 83.81M in revenue for fiscal year 2025, up from 73.24M in the previous year.

How much revenue did IRadimed Corp report in the most recent quarter?

IRadimed Corp reported 21.98M in revenue for the most recent quarter, an increase of 12.65% year over year.

What was IRadimed Corp's net income for the year?

IRadimed Corp posted 22.48M in net income for fiscal year 2025.

How much net income did IRadimed Corp post in the last quarter?

IRadimed Corp reported 5.82M in net income for the latest quarter。

What was IRadimed Corp's annual operating profit?

IRadimed Corp's operating income was 26.15M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.